Cubist Pharma Balance Sheet - Annual (NASDAQ:CBST)

Add to My Stocks
$101.94 $0.14 (0.14%) CBST stock closing price Jan 21, 2015 (Closing)

The financial analysis of a company like Cubist Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. As in our Cubist Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every year along with its annual results. The Cubist Pharma balance sheet for 2013 shows total assets of $3.15B. The company has a asset turnover ratio of . Also see: Cubist Pharma revenue and Cubist Pharma operating cash flow for the same year.

View latest 10 year balance sheet data to check Cubist Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201320122011201020092008
Cash91.05M104.04M197.61M372.96M157.31M409.02M
Marketable Securities487.5M872.18M670.07M516.84M161.68M-
Receivables123.15M93.46M87.8M61.19M57.82M43.16M
Inventory57.66M41.94M34.89M23.82M25.49M21.95M
Raw Materials17.9M9.13M6.01M7.69M9.35M10.37M
Work In Progress8.1M8.48M14.5M7.05M7.81M5.97M
Finished Goods31.65M24.33M14.36M9.07M8.32M5.61M
Notes Receivable------
Other Current Assets110.39M45.4M52.88M41.41M47.7M58.86M
Total Current Assets
869.76M1.16B1.04B1.02B450.02M533M
Property Plant & Equipment255.5M229.99M225.58M138.68M116.37M104.8M
Accumulated Depreciation77.95M63.52M57.16M56.24M47.99M37.99M
Net Property Plant & Equipment
177.54M166.46M168.42M82.43M68.38M66.81M
Investment & Advances-3.16M-20.1M177.16M8.92M
Other Non-Current Assets------
Deferred Charges-----81.38M
Intangibles1.1B266.96M297.11M75.3M79.8M19.72M
Deposits & Other Assets994.42M338.74M378.64M221.07M202.3M6.74M
Total Assets
3.15B1.93B1.89B1.42B977.67M716.59M
Notes Payable20.42M38.99M67.99M30.99M20M-
Accounts Payable31.87M45.6M32.58M23.48M18.66M11.57M
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses245.07M163.63M144.79M93.52M85.47M68M
Income Taxes Payable------
Other Current Liabilities13.44M10.28M7M2.64M2.07M1.89M
Total Current Liabilities
310.82M258.51M252.38M150.64M126.2M81.48M
Mortgages------
Deferred Taxes/Income388.81M137.17M170.69M103.41M50.01M19.44M
Convertible Debt------
Long-Term Debt1.02B518.02M634.48M491.3M326.98M300M
Non-Current Capital Leases------
Other Long-Term Liabilities31.72M27.92M30.03M6.37M3.81M3.69M
Total Liabilities
1.75B941.63M1.09B751.73M507.03M404.62M
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus1.36B940.96M904.28M800.61M702.24M578.14M
Retained Earnings31.2M49.77M-104.3M-137.32M-238.98M-266.22M
Treasury Stock------
Other Liabilities--0.05M-0.18M-7.31M-
Shareholders Equity1.39B990.74M799.85M663.42M470.64M311.97M
Total Liabilities & Shareholders Equity3.15B1.93B1.89B1.42B977.67M716.59M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Cubist Pharma stock price, and Cubist Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Cubist Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Cubist Pharma owns and has monetary significance. CBST assets grew from $1.93B in 2012 to $3.15B in 2013. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Cubist Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for CBST stock stand at $1.75B.

Annual Balance Sheets For Cubist Pharmaceuticals Inc Peers

AMNEAL PHARMACT balance sheet, Jazz Pharma balance sheet, Receptos balance sheet